Top

Reactions Weekly

Published in:

01-04-2024 | Adalimumab | Case report

Adalimumab/methylprednisolone/minocycline

Drug induced paradoxical psoriasis and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Fan D, et al. Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome and Paradoxical Psoriasis with Secukinumab: A Case Report. Clinical, Cosmetic and Investigational Dermatology 17 : 547-552, Jan 2024. Available from: URL: https://dx.doi.org/10.2147/CCID.S454057

Title: Adalimumab/methylprednisolone/minocycline
Drug induced paradoxical psoriasis and lack of efficacy
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keywords: Adalimumab
Minocycline
Vulgar Psoriasis
Secukinumab
Osteitis
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-56658-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adalimumab/methylprednisolone/minocycline

Drug induced paradoxical psoriasis and lack of efficacy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Dexamethasone/eptifibatide/remdesivir

Propranolol overdose

Lenvatinib

Atropine/Diazepam/Phenobarbital

Amiodarone

Baricitinib/Dexamethasone/Tenecteplase